Hypoxic Burden - A New Kid on the Block for Childhood OSA

22 Nov 2026 09:40 10:00
Albert M. Li Speaker Hong Kong
Childhood obstructive sleep apnoea (OSA) is a common condition linked to a range of complications, including neurocognitive and behavioural impairments, reduced quality of life, and elevated metabolic and cardiovascular risks. Adenotonsillectomy (AT) remains the first-line treatment, offering proven benefits across these domains. Timely diagnosis is therefore essential for early intervention and improved outcomes. Polysomnography (PSG) is the gold standard for diagnosing OSA. However, limited access leads to longer waiting periods. Moreover, the requirement for an overnight hospital stay can be particularly challenging for children. Given current limitations, there is a pressing need for a validated, user-friendly diagnostic tool to enable early and accurate identification of paediatric OSA. Recent research has shifted focus toward nocturnal hypoxaemia. A novel metric, the hypoxic burden (HB), first introduced by Azarbarzin et al., has shown superior predictive value for cardiovascular mortality than the apnoea-hypopnoea index (AHI) in adults. Despite its promise, HB has been criticised for its computational complexity. A more streamlined and accurate alternative, the oxygen desaturation burden index (OBI), has since emerged. This severity metric accounts for both the depth and duration of oxygen desaturations without requiring respiratory event scoring. Importantly, OBI can be derived from simple overnight oximetry, making it a more accessible and cost-effective option for home-based assessments. In this presentation, the speaker will discuss the usefulness of OBI and his research on using this parameter in interventional studies and in assessing cardiovascular complications in children with OSA.